| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/10/1992 | CA2088905A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |
| 02/09/1992 | WO1992002640A1 Cannabinoid receptor |
| 02/09/1992 | WO1992002621A2 Allergens of alder pollen and applications thereof |
| 02/09/1992 | CA2087844A1 Cannabinoid receptor |
| 02/09/1992 | CA2067144A1 Allergens of alder pollen and applications thereof |
| 02/07/1992 | CA2048305A1 Peptides with a characteristic antigenic determinant for alphal-microglobulin |
| 02/06/1992 | WO1992001936A1 Assay of free and complexed prostate-specific antigen (psa) |
| 02/06/1992 | WO1992001807A1 Means for diagnosis of ta and anti-ta antibodies and biological applications |
| 02/06/1992 | WO1992001791A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 02/06/1992 | WO1992001789A1 Stable and bioactive modified somatotropins |
| 02/06/1992 | WO1992001788A1 Beta chain of the human gm-csf receptor and uses thereof |
| 02/06/1992 | WO1992001783A1 Dna capable of site-specific integration into mycobacteria |
| 02/06/1992 | WO1992001782A2 Sucrose phosphate synthetase (sps), a preparation method and cdna therefor, and use of the cdna for modifying sps expression in plant cells |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001717A1 Bacterial stress proteins |
| 02/06/1992 | WO1992001716A1 Protease resistant pdgf and methods of use |
| 02/06/1992 | WO1992001713A1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 02/06/1992 | WO1992001707A1 Purification directed cloning of peptides |
| 02/06/1992 | WO1992001471A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | WO1992001460A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/06/1992 | CA2087853A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | CA2087160A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/05/1992 | EP0469897A2 Engineered antibodies |
| 02/05/1992 | EP0469359A2 Method and product for the treatment of gastric disease |
| 02/05/1992 | EP0469281A1 Amino acid residue sequence of hepatitis B core antigen |
| 02/05/1992 | EP0469025A1 Improvements in or relating to enhancers. |
| 02/04/1992 | WO1992002617A1 Use of crosslinked crystals as a novel form of enzyme immobilization |
| 02/04/1992 | US5086164 Novel methods and compositions for treatment of angiogenic diseases |
| 02/04/1992 | US5086040 Novel dermatological composition and method |
| 02/04/1992 | US5085990 Teicoplanin-like derivatives |
| 02/04/1992 | US5085862 Mutants, vaccine; immunoprotective in mice |
| 02/04/1992 | CA1295269C Polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon |
| 02/04/1992 | CA1295242C FORMULATIONS SUITABLE FOR THE STABILISATION OF .alpha.-INTERFERON |
| 02/04/1992 | CA1295241C Lymphokine and its production and uses |
| 02/03/1992 | WO1992002817A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 02/03/1992 | WO1992002628A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | WO1992002251A1 Herpes simplex virus vp16 vaccines |
| 02/03/1992 | CA2088599A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | CA2066174A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/02/1992 | WO1992002540A1 Method for purifying a protein present in an inclusion body |
| 02/02/1992 | CA2066598A1 Process for the purification of a protein in inclusion bodies |
| 02/01/1992 | CA2048029A1 Amino acid residue sequence of hepatitis b core antigen |
| 01/30/1992 | DE4107765A1 Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt Pancreatic elastase-1-specific antibodies, a process for its production and to a test kit which such antibody contains |
| 01/30/1992 | DE4023945A1 Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern A process for purification of cytokeratin 20 and its use for the production of antibodies |
| 01/30/1992 | DE4023721A1 Modified Gram negative bacteria for use as vaccine and adjuvant - are transformed to express lytic protein or toxin, forming ghost(s) which present many cell wall epitope(s) |
| 01/29/1992 | WO1992002630A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
| 01/29/1992 | EP0468764A1 Method for administering a therapeutic anticoagulant |
| 01/29/1992 | EP0468637A1 In vivo targeting with bifunctional antibodies |
| 01/29/1992 | EP0468601A1 Methods and materials for HIV detection and therapy |
| 01/29/1992 | EP0468539A1 Hirudin derivatives |
| 01/29/1992 | EP0468504A1 A novel antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 01/29/1992 | EP0468393A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/29/1992 | EP0468337A1 DNA coding for a human vasoconstrictive peptide and use thereof |
| 01/29/1992 | EP0468257A1 Multimeric form of human rhinovirus receptor protein |
| 01/29/1992 | EP0468056A1 Anti-procollagenase monoclonal antibodies and a method for the assay of procollagenase utilizing thereof |
| 01/29/1992 | EP0468049A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen |
| 01/29/1992 | EP0467972A1 Rickettsial antigens for vaccination and diagnosis |
| 01/29/1992 | EP0467965A1 Plasmodium circumsporozoite protein analogs lacking repeat sequences |
| 01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
| 01/28/1992 | US5084561 Using a zwitterion detergent and extraction |
| 01/28/1992 | US5084559 Protein a domain mutants |
| 01/28/1992 | US5084396 Monoclonal antibodies absorbed onto a matrix and binding, mixing with a polyvalent antigen to form an immune complex, immunizing animals, fusion spleen cells to form hybridomas and culturing |
| 01/28/1992 | US5084391 Monoclonal antibody to the interleukin-2-receptor and its use |
| 01/28/1992 | US5084383 Producing a protein by linking, 5' to 3', and a promoter, a sequencer coding for a peptide, genetic engineering, cultures |
| 01/28/1992 | CA1295087C Purification of recombinant beta-interferon incorporating rp-hplc |
| 01/28/1992 | CA1294905C Anti-lafora body monoclonal antibody |
| 01/28/1992 | CA1294904C Progesterone assay method for mammals |
| 01/28/1992 | CA1294901C Monoclonal antibody specific for human colon fibroblast-derived t-pa |
| 01/28/1992 | CA1294873C Method of regulating animal reproduction |
| 01/26/1992 | WO1992001787A1 Binding domains |
| 01/26/1992 | WO1992001465A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 01/26/1992 | CA2087979A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 01/26/1992 | CA2087095A1 Binding domains |
| 01/26/1992 | CA2047769A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/25/1992 | WO1992001790A1 Endogenously sweetened transgenic plant products |
| 01/25/1992 | WO1992001712A1 Analogs of hirudin |
| 01/25/1992 | CA2066749A1 Analogs of hirudin |
| 01/25/1992 | CA2047527A1 Method for administering a therapeutic anticoagulant |
| 01/25/1992 | CA2031288A1 Method for obtaining antibody antigen binding fragments prepared from bacteria |
| 01/24/1992 | WO1992001795A1 Gamma-carboxylase and methods of use |
| 01/24/1992 | CA2087970A1 Gamma-carboxylase and methods of use |
| 01/23/1992 | WO1992001059A1 Cdr grafted anti-cea antibodies and their production |
| 01/23/1992 | WO1992001057A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | WO1992001056A1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 01/23/1992 | WO1992001054A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 01/23/1992 | WO1992001052A1 Dna coding for human fk506-binding protein and expression thereof |
| 01/23/1992 | WO1992001050A1 Novel receptor-type phosphotyrosine phosphatase |
| 01/23/1992 | WO1992001049A2 Cd53 cell surface antigen and use thereof |
| 01/23/1992 | WO1992001047A1 Methods for producing members of specific binding pairs |
| 01/23/1992 | WO1992001040A1 Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor |
| 01/23/1992 | WO1992001000A1 Basophil granule proteins |
| 01/23/1992 | WO1992000999A1 Fibroblast growth factor receptors |
| 01/23/1992 | WO1992000993A1 Isolation and purification of lung surfactant protein |
| 01/23/1992 | WO1992000757A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | CA2087008A1 Novel receptor-type phosphotyrosine phosphatase |
| 01/23/1992 | CA2086932A1 Basophil granule proteins |
| 01/23/1992 | CA2086829A1 Diagnosis of metastatic cancer by the mts-1 gene |
| 01/23/1992 | CA2086739A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | CA2086330A1 Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor |
| 01/22/1992 | EP0467839A1 In vitro processing of fusion proteins |